Attached files
| file | filename |
|---|---|
| EX-31.2 - EXHIBIT 31.2 - ESCALON MEDICAL CORP | esmc_20170930-10q2018ex312.htm |
| EX-32.1 - EXHIBIT 32.1 - ESCALON MEDICAL CORP | esmc_20170930-10q2018ex321.htm |
| EX-31.1 - EXHIBIT 31.1 - ESCALON MEDICAL CORP | esmc_20170930-10q2018ex311.htm |
| 10-Q - 10-Q - ESCALON MEDICAL CORP | esmc_20170930-10q2018.htm |
Exhibit 32.2
Certification pursuant to 18 U.S.C. Section 1350,
as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
I, Robert M. O’Connor, Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. §1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:
1. | The Quarterly Report of Escalon Medical Corp. on Form 10-Q for the quarterly period ended September 30, 2017 fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and |
2. | The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. |
Date: November 14, 2017
/s/ Mark Wallace | |
Mark Wallace | |
Chief Operating Officer and Principal Accounting & Financial Officer | |